US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology Industry Research & Market Reports

3  4  5  6    8    10  11  12  
Cell Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
5/29/2015 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Cell Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
TiGenix N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
5/29/2015 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' TiGenix N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Bayer CropScience AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
5/29/2015 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Bayer CropScience AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Oxygen Biotherapeutics, Inc. (formerly Synthetic Blood International, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
5/29/2015 | published by: MarketLine
... a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Oxygen Biotherapeutics, Inc. (formerly Synthetic Blood International, Inc.) Mergers & Acquisitions (M&A), Partnerships ...  |  read more...
USD 350
Novartis AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
5/29/2015 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Novartis AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
Global Nomilin Industry 2015 Market Research Report
5/18/2015 | published by: 9Dimen Research
... the main countries (United States, Germany, Japan and China). The report firstly introduced the Nomilin basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so ...  |  read more...
USD 2,850
Celltrion, Inc. (068270) - Financial and Strategic SWOT Analysis Review
5/4/2015 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
MacroGenics, Inc. (MGNX) - Financial and Strategic SWOT Analysis Review
5/4/2015 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Global Sophoricoside Industry 2015 Market Research Report
5/18/2015 | published by: 9Dimen Research
... the main countries (United States, Germany, Japan and China). The report firstly introduced the Sophoricoside basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so ...  |  read more...
USD 2,850
The 2016 Report on DNA Chips: World Market Segmentation by City
4/30/2015 | published by: Icon Group International, Inc.
... a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so by reporting ...  |  read more...
USD 995
North America Spine Surgery Devices Market by Product (Non-Fusion Implants, Spinal Fusion and Fixation Devices, Spine Biologics, Spine Bone Stimulators, VCFT Devices), by End User (Hospitals, Orthopedic Clinics), by Geography - Analysis and Forecast to 20
5/11/2015 | published by: MicroMarketMonitor
... market, by product type, encompasses spinal fusion and fixation devices, spine biologics devices, VCF treatment devices, non-fusion implant devices, and spine bone stimulators devices. Of these, the spinal fusion and fixation devices segment is the ...  |  read more...
USD 2,650
Genome Editing / Genome Engineering Market by Application (Cell Line Engineering, Animal & Plant Genetic Engineering), Technology (CRISPR, Antisense, TALEN, Zinc Finger Nuclease) & End User (Biotechnology & Pharmaceutical, CRO) - Global Forecast to 2019
5/7/2015 | published by: MarketsandMarkets
... 2019 In this report, the genome editing market is segmented on the basis of applications, technologies, end users, and regions. The application segments included in this report are cell line engineering, animal genetic engineering, plant ...  |  read more...
USD 4,650
Anika Therapeutics, Inc. (ANIK) - Product Pipeline Analysis, 2015 Update
5/19/2015 | published by: GlobalData
... of its major products include non-animal sourced viscosupplements, advanced wound care devices, anti-adhesion gels, dental bone grafting adjuncts and joint dysfunction management fluids for horses, among others. Its products are made from hyaluronic acid (HA) ...  |  read more...
USD 750
Cyclopharm Limited (CYC) - Financial and Strategic SWOT Analysis Review
5/19/2015 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 300
Discovery Laboratories, Inc. (DSCO) - Financial and Strategic SWOT Analysis Review
5/19/2015 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Marina Biotech, Inc. (MRNA) - Financial and Strategic SWOT Analysis Review
5/19/2015 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Osiris Therapeutics, Inc. (OSIR) - Financial and Strategic SWOT Analysis Review
5/19/2015 | published by: GlobalData
... to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to ...  |  read more...
USD 125
Oxford Biodynamics Limited - Product Pipeline Analysis, 2015 Update
5/19/2015 | published by: GlobalData
... gene expression. It concentrates on research in detection, monitoring and prognosis of major diseases associated with aberrant gene expression including oncology, inflammatory, metabolic, cardiovascular and neurodegenerative conditions. The company's products find applications in the areas ...  |  read more...
USD 750
2015 Strategies in the Spanish Tumor Marker Testing Market
5/15/2015 | published by: VPGMarketResearch.com
... during the next five years. Mortality statistics and scientific views on the etiology of major types of cancer, e.g., lung, colorectal, breast, prostatic, pancreatic, leukemia, lymphoma, gastrointestinal, bladder, liver, ovarian, testicular, oral, skin and others. ...  |  read more...
USD 6,800
Anti-CD37 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD37 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD37 Antibody- ...  |  read more...
USD 1,250
Anti-CD4 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD4 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD4 Antibody- ...  |  read more...
USD 1,250
Anti-CD40 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD40 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD40 Antibody- ...  |  read more...
USD 1,250
Anti-CD6 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD6 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD6 Antibody- ...  |  read more...
USD 1,250
Anti-CD70 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CD70 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CD70 Antibody- ...  |  read more...
USD 1,250
Anti-CS1 Antibody -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Anti-CS1 Antibody Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Anti-CS1 Antibody- ...  |  read more...
USD 1,250
3  4  5  6    8    10  11  12